Literature DB >> 26519939

Does progranulin account for the opposite effects of etanercept and infliximab/adalimumab in osteoarthritis?: Comment on Olson et al.: "Therapeutic Opportunities to Prevent Post-Traumatic Arthritis: Lessons From the Natural History of Arthritis After Articular Fracture".

Jian-Lu Wei1, John Buza1, Chuan-Ju Liu1,2.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26519939      PMCID： PMC4710548          DOI： 10.1002/jor.23091

Source DB:  PubMed          Journal:  J Orthop Res        ISSN： 0736-0266            Impact factor:   3.494


× No keyword cloud information.
  35 in total

1.  Therapeutic opportunities to prevent post-traumatic arthritis: Lessons from the natural history of arthritis after articular fracture.

Authors:  Steven A Olson; Bridgette D Furman; Virginia B Kraus; Janet L Huebner; Farshid Guilak
Journal:  J Orthop Res       Date:  2015-06-07       Impact factor: 3.494

Review 2.  Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.

Authors:  Bharat B Aggarwal; Subash C Gupta; Ji Hye Kim
Journal:  Blood       Date:  2011-11-03       Impact factor: 22.113

3.  Progranulin directly binds to the CRD2 and CRD3 of TNFR extracellular domains.

Authors:  Jinlong Jian; Shuai Zhao; Qingyun Tian; Elena Gonzalez-Gugel; Jyoti Joshi Mundra; Sardar M Z Uddin; Ben Liu; Brendon Richbourgh; Ryan Brunetti; Chuan-ju Liu
Journal:  FEBS Lett       Date:  2013-09-23       Impact factor: 4.124

4.  The growth factor progranulin binds to TNF receptors and is therapeutic against inflammatory arthritis in mice.

Authors:  Wei Tang; Yi Lu; Qing-Yun Tian; Yan Zhang; Feng-Jin Guo; Guang-Yi Liu; Nabeel Muzaffar Syed; Yongjie Lai; Edward Alan Lin; Li Kong; Jeffrey Su; Fangfang Yin; Ai-Hao Ding; Alexandra Zanin-Zhorov; Michael L Dustin; Jian Tao; Joseph Craft; Zhinan Yin; Jian Q Feng; Steven B Abramson; Xiu-Ping Yu; Chuan-ju Liu
Journal:  Science       Date:  2011-03-10       Impact factor: 47.728

Review 5.  Bone fracture and bone fracture repair.

Authors:  N L Fazzalari
Journal:  Osteoporos Int       Date:  2011-06       Impact factor: 4.507

6.  Anti-inflammatory and cartilage-protecting effects of an intra-articularly injected anti-TNF{alpha} single-chain Fv antibody (ESBA105) designed for local therapeutic use.

Authors:  D M Urech; U Feige; S Ewert; V Schlosser; M Ottiger; K Polzer; G Schett; P Lichtlen
Journal:  Ann Rheum Dis       Date:  2009-03-16       Impact factor: 19.103

7.  Selective tumor necrosis factor receptor I blockade is antiinflammatory and reveals immunoregulatory role of tumor necrosis factor receptor II in collagen-induced arthritis.

Authors:  Fiona E McCann; Dany P Perocheau; Gerhard Ruspi; Katrina Blazek; Marie L Davies; Marc Feldmann; Jonathan L E Dean; A Allart Stoop; Richard O Williams
Journal:  Arthritis Rheumatol       Date:  2014-10       Impact factor: 10.995

8.  PGRN protects against colitis progression in mice in an IL-10 and TNFR2 dependent manner.

Authors:  Fanhua Wei; Yuying Zhang; Jinlong Jian; Jyoti Joshi Mundra; Qingyun Tian; Jiqiang Lin; Juan Jose Lafaille; Wei Tang; Weiming Zhao; Xiuping Yu; Chuan-Ju Liu
Journal:  Sci Rep       Date:  2014-11-12       Impact factor: 4.379

9.  Targeting tumour necrosis factor alleviates signs and symptoms of inflammatory osteoarthritis of the knee.

Authors:  Walter P Maksymowych; Anthony S Russell; Peter Chiu; Alex Yan; Niall Jones; Tracey Clare; Robert G W Lambert
Journal:  Arthritis Res Ther       Date:  2012-10-04       Impact factor: 5.156

10.  Protective effects of tumor necrosis factor-α blockade by adalimumab on articular cartilage and subchondral bone in a rat model of osteoarthritis.

Authors:  C H Ma; Q Lv; Y X Yu; Y Zhang; D Kong; K R Niu; C Q Yi
Journal:  Braz J Med Biol Res       Date:  2015-07-31       Impact factor: 2.590
View more
  7 in total

Review 1.  Progranulin: A conductor of receptors orchestra, a chaperone of lysosomal enzymes and a therapeutic target for multiple diseases.

Authors:  Yazhou Cui; Aubryanna Hettinghouse; Chuan-Ju Liu
Journal:  Cytokine Growth Factor Rev       Date:  2019-01-30       Impact factor: 7.638

Review 2.  Multifunctional molecule ERp57: From cancer to neurodegenerative diseases.

Authors:  Aubryanna Hettinghouse; Ronghan Liu; Chuan-Ju Liu
Journal:  Pharmacol Ther       Date:  2017-07-16       Impact factor: 12.310

Review 3.  Progranulin: A key player in autoimmune diseases.

Authors:  Jinlong Jian; Guangfei Li; Aubryanna Hettinghouse; Chuanju Liu
Journal:  Cytokine       Date:  2016-08-12       Impact factor: 3.861

4.  Progranulin suppresses titanium particle induced inflammatory osteolysis by targeting TNFα signaling.

Authors:  Yun-peng Zhao; Jian-lu Wei; Qing-yun Tian; Alexander Tianxing Liu; Young-su Yi; Thomas A Einhorn; Chuan-ju Liu
Journal:  Sci Rep       Date:  2016-02-11       Impact factor: 4.379

5.  Progranulin derivative Atsttrin protects against early osteoarthritis in mouse and rat models.

Authors:  Jian-Lu Wei; Wenyu Fu; Yuan-Jing Ding; Aubryanna Hettinghouse; Matin Lendhey; Ran Schwarzkopf; Oran D Kennedy; Chuan-Ju Liu
Journal:  Arthritis Res Ther       Date:  2017-12-19       Impact factor: 5.156

Review 6.  Review: Novel Insights Into Tumor Necrosis Factor Receptor, Death Receptor 3, and Progranulin Pathways in Arthritis and Bone Remodeling.

Authors:  Anwen Williams; Eddie C Y Wang; Lorenz Thurner; Chuan-Ju Liu
Journal:  Arthritis Rheumatol       Date:  2016-12       Impact factor: 10.995

7.  Tunicamycin suppresses breast cancer cell growth and metastasis via regulation of the protein kinase B/nuclear factor-κB signaling pathway.

Authors:  Xiaoli Wang; Wei Xiong; Yiyin Tang
Journal:  Oncol Lett       Date:  2018-01-26       Impact factor: 2.967
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.